-
ECCMID 2023 | JOINSTAR INFECTION DISEASE BIOMARKERS SHOWCASED
Joinstar attended the prestigious 33rd European Congress of Clinical Microbiology & Infectious Diseases, where the experts from all over the world gathered in Copenhagen. A key feature of the Congress was Sepsis and related inflammatory diseases in terms of their dia...Read more -
ISICEM 2023 (Belgium) JOINSTAR RAPID HBP TEST SHOWCASED
At this International Critical Care meeting the Jet-iStar platforms (JS 800 and JS800 Plus) and the full range of Point-of-Care assays were presented with a special focus on Heparin Binding Protein (HBP), a novel patented biomarker which has been shown to play a key role in the management of Seps...Read more -
HBP: from 2012 to 2022|Jet-iStar800|Returned to the laboratory at Lund University in Sweden
In 2012, JOINSTAR obtained the application patent authorization of Heparin Binding Protein, becoming the exclusive Chinese enterprise to obtain the PATENT authorization of HBP. HBP was also introduced from Lund University in Sweden, Axis-Shield Diagnostics Ltd. The picture shows Dr. Adam Linde ...Read more
